不安とストレス  不安の多様性とセロトニン神経系

  • 辻 稔
    東京医科大学薬理学講座 難病治療研究センター(創薬部門)
  • 武田 弘志
    東京医科大学薬理学講座 難病治療研究センター(創薬部門)
  • 松宮 輝彦
    東京医科大学薬理学講座 難病治療研究センター(創薬部門)

書誌事項

タイトル別名
  • Anxiety and Stress. Multiplicity of anxiety and serotonin nervous system.
  • フアン ト ストレス
  • 不安とストレス

この論文をさがす

抄録

It has been recently suggested that the central serotonin (5-HT) nervous system may be involved in the modulation of anxiety. Especially, the possible importance of 5-HT1A receptors in anxiety was raised by evidence that the anxiolytic properties of 5-HT1A-receptor agonists have now been confirmed in clinical studies. On the other hand, in preclinical studies using various animal models of anxiety, these novel agents tend to have weak and/or variable effects in some paradigms used to detect the anxiolytic activities of benzodiazepines. These differential patterns of drug effects within various models promote the concept of “multiplicity of anxiety”. Recently, a new experimental model called the T-maze was developed in attempts to analyze a different type of anxiety; i.e., conditioned fear and unconditioned fear response. The results of a series of behavioral studies using the T-maze test suggest that distinct 5-HT pathways may modulate the different classes of anxiety. In our recent studies using the hole-board test, apparent differential behavioral effects between benzodiazepine anxiolytics and 5-HT1A agonists on emotionality of stressed mice were also observed. These results suggest that benzodiazepine or 5-HT1A receptors may play a different role in modulating emotionality. These studies may provide new information to investigate the pathophysiological characteristics of various types of anxiety disorders and to develop novel therapeutic agents.

収録刊行物

参考文献 (50)*注記

もっと見る

詳細情報 詳細情報について

問題の指摘

ページトップへ